U87-MG-luc Orthotopic Model
U87-MG-luc is a luminescent glioblastoma cell line derived from U87-MG. It expresses luciferase, allowing for non-invasive monitoring of tumor growth and response to therapies using bioluminescence imaging techniques. U87-MG-luc serves as a valuable model for studying glioblastoma multiforme (GBM) and evaluating therapeutic strategies. Researchers utilize this cell line to investigate GBM biology, test novel treatments, and assess drug efficacy in preclinical studies.
Cancer Type: Brain Cancer
Model Name: U87-MG-luc
Mouse Strain: Nu/Nu
Treatment Data Available: Chemotherapy (Temolozide)
Survival of U87-MG-luc after orthotopic intracranial injection in Nu/Nu mice (n=10)